Guess?, Inc. (NYSE: GES) today reported financial results for its fourth quarter and full fiscal year ended February 1, 2025.

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, ...

Total Revenues of $141.4M, up 14% year-over-year Fiscal Year 2025 Total Revenues of $540.7M, up 13% year-over-year Q4 Subscription Revenues of ...

The Company’s outlook for the first quarter and full fiscal year 2026 assumes that foreign currency exchange rates remain at recently prevailing rates. Amounts for the first quarter and full ...

Revenues for the year ended December 31, 2024, totaled $23.3 million, a decrease of 54% compared to $50.7 million in 2023. This decline was primarily driven by a combination of lower WTI oil prices ...

Velo3D, headquartered in Fremont, California, USA, has announced its financial results from the fourth quarter and fiscal ...

(2)Adjusted EBITDA and Adjusted EBITDA excluding FX are non-GAAP financial measures. Reconciliations are provided in the tables of this press release.

ROCHESTER, N.Y., April 09, 2025 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its fiscal year and fourth quarter 2025 financial results ...

today announced financial results for its fourth quarter and fiscal year ended February 4, 2025. The Company's fiscal 2024 consisted of 13 weeks in the fourth quarter and 52 weeks in the fiscal ...

Assuming a comparable full year of OWYN results are included in fiscal year 2024, as well as the exclusion of the fifty-third week in fiscal year 2024, fiscal year 2025 is expected to be in line with ...